Thomas A. Fitzgerald - Sep 28, 2023 Form 4 Insider Report for Transcode Therapeutics, Inc. (RNAZ)

Role
Chief Financial Officer, Director
Signature
/s/ Thomas A. Fitzgerald
Stock symbol
RNAZ
Transactions as of
Sep 28, 2023
Transactions value $
$25,169
Form type
4
Date filed
10/2/2023, 04:39 PM
Previous filing
May 19, 2023
Next filing
Jun 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNAZ Common Stock Purchase $25.2K +49.4K +708.24% $0.51 56.3K Sep 28, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired pursuant to an underwritten public offering of common stock by the Issuer.
F2 Reported amount reflects a 1-for-20 reverse stock split of the Issuer's common stock, which became effective as of May 22, 2023.